Director, Pharmacovigilance Scientist

Cullinan Therapeutics is a biopharmaceutical company developing potential first- or best-in-class, high-impact therapies for autoimmune diseases and cancer. Cullinan pursues promising therapeutic targets while leveraging core expertise in T cell engagers, which are established in oncology and are now advancing into autoimmune diseases. With a clinical-stage pipeline built on a rigorous scientific approach and purposeful innovation, Cullinan is advancing its mission to deliver new standards of care for patients. The Pharmacovigilance Scientist (PVS) participates in the development and planning of safety strategies for assigned products in early clinical development (Phase I and II clinical studies). This will include safety data aggregation, review and analysis to support appropriate safety interpretation and benefit-risk assessment. PVS will play essential role in developing PV/Safety documents in collaboration with other PV team members and cross-functional teams e.g., medical, clinical operations, biostatistics, and regulatory affairs.